Table 3.
Patient's characteristics of matched HIV-seropositive patients and HIV-seronegative patients matched for TNM-stage and age (n = 10 vs. 10).
| Variable | Study group | Fisher's exact test | |
| HAART-HIV + | HIV - | ||
| gender | m:f = 9:1 (90%) | m:f = 1:9 (10%) | 0.001 |
| age (mean) | 44.5 +/- 10 y | 45.2 +/- 7 y | NS |
| WHO-perform. Status I° | 2 (20 %) | 0 | NS |
| T1 | 2 | 2 | NS |
| T2 | 6 | 6 | NS |
| T3 | 2 | 2 | NS |
| N0 | 9 | 9 | NS |
| N2 | 1 | 1 | NS |
| G1 | 2 | NS | |
| G2 | 6 | 8 | NS |
| G3 | 2 | NS | |
| Sphincter invasion | 2 (22 %) | 3 (30 %) | NS |
| Histology (basaloid) | 2 (20 %) | 4 (40 %) | NS |
| Mitomycin C | 6 (60 %) | 8 (80 %) | NS |
| Brachytherapy | 0 (0 %) | 6 (60 %) | 0.005 |
| RT-dose (mean) | 57.7 +/- 2.4 Gy | 58.5 +/- 3 Gy | NS |